Jan Matouš

Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study

Marc Ferrante, Geert D’Haens, Vipul Jairath et al. · The Lancet · 2024 · 76 citations

Moderately-to-severely Active Crohn, Immunology, Gastroenterology +5

Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies

David T. Rubin, Jessica R. Allegretti, Julián Panés et al. · The Lancet · 2024 · 62 citations · Full text

Placebo-controlled Induction, Gastroenterology, Pathology +6

ERCP in infants, children, and adolescents—Different roles of the methods in different age groups

Radan Keil, Jindra Lochmannová, Jan Šťovíček et al. · PLoS ONE · 2019 · 51 citations · Full text

A head-to-head comparison of 4-L polyethylene glycol and low-volume solutions before colonoscopy: which is the best? A multicentre, randomized trial

Vladimír Kojecký, Jan Matouš, Radan Keil et al. · International Journal of Colorectal Disease · 2017 · 15 citations

Gastroenterology, Gi Technique, Surgery +7

The optimal bowel preparation intervals before colonoscopy: A randomized study comparing polyethylene glycol and low-volume solutions

Vladimír Kojecký, Jan Matouš, Radan Keil et al. · Digestive and Liver Disease · 2017 · 14 citations

Randomized Study, Gastroenterology, Gi Technique +6